UBS Group
NUVB.WS

UBS Group’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

UBS Group’s Portfolio NUVB.WS Stock Details NUVB.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-99
Closed -$27 – 10738
2025
Q2 		$27 Sell
99
-2,507
-96% -$579 ﹤0.01% 10100
2025
Q1 		$516 Buy
2,606
+2,571
+7,346% +$657 ﹤0.01% 9749
2024
Q4 		$8 Buy
+35
New +$5 ﹤0.01% 9818
2024
Q2 		– Sell
-100
Closed -$30 – 9922
2024
Q1 		$30 Buy
+100
New +$12 ﹤0.01% 8990
2023
Q4 		– Sell
-84
Closed -$8 – 9724
2023
Q3 		$8 Buy
+84
New +$11 ﹤0.01% 9241
2023
Q1 		– Sell
-505
Closed -$71 – 10127
2022
Q4 		$71 Sell
505
-1,660
-77% -$222 ﹤0.01% 10443
2022
Q3 		$0 Hold
2,165
– – ﹤0.01% 10735
2022
Q2 		$1K Buy
2,165
+208
+11% +$134 ﹤0.01% 9921
2022
Q1 		$1K Sell
1,957
-34
-2% -$34 ﹤0.01% 9892
2021
Q4 		$4K Sell
1,991
-9
-0.5% -$20 ﹤0.01% 9535
2021
Q3 		$5K Sell
2,000
-1,801
-47% -$4.22K ﹤0.01% 8546
2021
Q2 		$10K Sell
3,801
-5,053
-57% -$16.5K ﹤0.01% 8055
2021
Q1 		$24K Buy
+8,854
New +$25.6K ﹤0.01% 7207

Other funds holding NUVB.WS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
GCM
Greenland Capital Management New York $812M AUM 45.54% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group's NUVB.WS Position: Q3 2025 in Review

UBS Group sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q3 2025, closing a stake of 99 shares — an estimated $27 sold.

UBS Group first reported a position in NUVB.WS in Q1 2021 and held it in 13 quarters. The position peaked at $24K in Q1 2021. 22 funds tracked by Wall St. Rank hold NUVB.WS as of Q3 2025.

  • UBS Group reported no remaining Nuvation Bio Inc Warrants position as of Q3 2025 after selling out during the quarter.
  • UBS Group sold 99 Nuvation Bio Inc Warrants shares in Q3 2025, an estimated $27.
  • UBS Group first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 13 quarters.
  • UBS Group's Nuvation Bio Inc Warrants position peaked at $24K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q3 2025.

Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.